Menu

Chemical Genomics: Undruggables and the Quest for Therapeutics

The Scientist is bringing together a panel of experts to discuss chemical genomics and the advances and promises it brings to therapeutic discovery

Apr 29, 2019
The Scientist Creative Services Team

FREE Webinar

Wednesday, August 7, 2019
2:30-4:00 PM Eastern Time
Register Now

When the human genome was mapped in the early 2000s, researchers at the time were hopeful that knowing the blueprint of every disease-causing protein in the body would swiftly lead to treatments. Although mapping the human genome did help to uncover various disease-causing proteins, almost two decades later it’s now clear that the complex biology of disease combined with the endless task of screening small molecules means many of these targets remain undruggable. However, chemical genomics, defined as the systematic screening of libraries of small molecules against various drug target families, promises hope to remedy this vast gap in therapeutics. Numerous high-throughput screening assays and chemical probes are employed in chemical genomics, many of which have been adapted from large-scale technologies within the pharmaceutical industry. To learn more about chemical genomics and the advances and promises it brings to therapeutic discovery, The Scientist is bringing together a panel of researchers in the chemical genomics field for this free educational webinar.

Topics to be covered:

  • Roadblocks and opportunities for protected open innovation in pharmaceutical R&D
  • Patient lead approaches to identify novel targets with chemical genomics

Register Now

Meet the Speakers:

Mel Reichman, PhD
Senior Investigator, Director, Chemical Genomics Center
CSO Small Molecule R&D
Lankenau Institute for Medical Research (LIMR)

John P. Overington, PhD
Chief Informatics Officer
Catapult Medicines Discovery, UK

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Best Practices: Calculating Cell Confluency
Best Practices: Calculating Cell Confluency
In this white paper, learn how to use a cell imager system to directly and accurately capture and calculate cell confluency!
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab. 
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
LabTwin GmbH, an independent company backed by Boston Consulting Group Digital Ventures (BCG Digital Ventures) and leading biopharma supplier, Sartorius, today announced the launch of the world's first voice and AI-powered digital lab assistant.
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
When analyzing large transcriptomics or proteomics datasets, we want to understand whether the phenomenon is unusual or commonplace and whether there are informative similarities to other areas of biology. To learn more about how Ingenuity Pathway Analysis (IPA®) and Analysis Match can help, download this white paper from QIAGEN!